ARCHIVES

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

This article is from The Cancer Letter archive.

Vol. 40 No. 04 | January 24, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

In Brief: NIH Study Finds Intramural Program Tenures Few Minorities, Calls For Improvements

March 11, 1994

Clinical Trials: NCI Forms Panel To Help Implement Recommendations

December 12, 1997

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

Congress Reaffirms GRH FY 1986 Cuts

July 25, 1986